Shares of Ainos, Inc. (OTCMKTS:AIMD – Get Free Report) traded up 3.6% during mid-day trading on Thursday . The company traded as high as $0.48 and last traded at $0.48. 28,797 shares traded hands during trading, a decline of 97% from the average session volume of 930,280 shares. The stock had previously closed at $0.46.
Ainos Stock Down 1.7 %
The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.45 and a current ratio of 1.92. The firm has a market capitalization of $6.49 million, a price-to-earnings ratio of -0.19 and a beta of 1.40. The firm has a fifty day moving average price of $0.49 and a 200 day moving average price of $0.67.
Ainos Company Profile
Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.
Further Reading
- Five stocks we like better than Ainos
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Penny Stocks Ready to Break Out in 2025
- The Most Important Warren Buffett Stock for Investors: His Own
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
